Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Dotarem Versus Gadovist for LGE-CMR
NCT03057561Completed
- Sponsor
- Houston Methodist Research Institute
- Start
- Oct 2016
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
Randomised trial of gadoterate meglumine in cardiovascular disease (CVD) (2 arms), sponsored by Houston Methodist Research Institute. Primary endpoints: Visual image quality of LGE-CMR at 2 years, Quantitative signal enhancement of LGE at 2 years and 1 more. Started Oct 2016; status: completed.
02
Drugs
gadoterate meglumine
03
Conditions
cardiovascular disease (CVD)
Beyond the preview
Go deeper on NCT03057561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03057561.